Article
Methylglyoxal-derived advanced glycation end products contribute to negative cardiac remodeling and dysfunction post-myocardial infarction.
Basic research in cardiology - 1 Sept 2017
Blackburn Nick J R, Vulesevic Branka, McNeill Brian, Cimenci Cagla Eren, Ahmadi Ali, Gonzalez-Gomez Mayte, Ostojic Aleksandra, Zhong Zhiyuan, Brownlee Michael, Beisswenger Paul J, Milne Ross W, Suuronen Erik J
Abstract excerpt
Advanced glycation end-products (AGEs) have been associated with poorer outcomes after myocardial infarction (MI), and linked with heart failure. Methylglyoxal (MG) is considered the most important AGE precursor, but its role in MI is unknown. In this study, we investigated the involvement of MG-derived AGEs (MG-AGEs) in MI using transgenic mice that over-express the MG-metabolizing enzyme glyoxalase-1 (GLO1). MI...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
